tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Health Catalyst Reports Strong Q2 2025 Results

Health Catalyst Reports Strong Q2 2025 Results

Health Catalyst ( (HCAT) ) has released its Q2 earnings. Here is a breakdown of the information Health Catalyst presented to its investors.

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

Health Catalyst, Inc. is a prominent provider of data and analytics technology and services aimed at enhancing healthcare outcomes, operating primarily within the healthcare sector. The company is known for its cloud-based technology ecosystem, Health Catalyst Ignite™, which leverages AI-enabled solutions to drive clinical, financial, and operational improvements across numerous healthcare organizations globally.

In its latest earnings report for the second quarter of 2025, Health Catalyst reported a total revenue of $80.7 million, surpassing its quarterly guidance. The company also achieved an Adjusted EBITDA of $9.3 million, marking a significant improvement over the previous year. Additionally, CEO Dan Burton announced his retirement effective June 30, 2026, after 15 years of leadership, with plans to pursue mission-oriented service opportunities.

Key financial metrics for the quarter included a 6% increase in total revenue compared to the same period last year, reaching $80.7 million. Despite this growth, the company reported a net loss of $40.978 million, largely attributed to a $28.8 million goodwill impairment. On a positive note, Adjusted EBITDA saw a 24% increase year-over-year, reaching $9.344 million. The company also highlighted its strategic focus on restructuring and profitability improvements, anticipating an annualized EBITDA improvement of over $40 million.

Looking ahead, Health Catalyst has provided guidance for the third quarter of 2025, expecting total revenue of approximately $75 million and Adjusted EBITDA of about $10.5 million. For the full year, the company projects total revenue of approximately $310 million and Adjusted EBITDA of $41 million. Despite macroeconomic challenges, the company remains confident in its ability to enhance profitability and maintain strong client relationships.

As Health Catalyst navigates these transitions, the company is committed to continuing its mission of driving measurable improvements in healthcare through innovative data and analytics solutions, while ensuring a smooth leadership transition to sustain its growth trajectory.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1